Covered recipient · General Payments record
WILLIAM C LIVINGSTON
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$729.43
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $301.04 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $128.17 | 1 |
| Madrigal Pharmaceuticals | $43.28 | 2 |
| ABBVIE INC. | $38.06 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.46 | 1 |
| GENZYME CORPORATION | $25.38 | 1 |
| IRONWOOD PHARMACEUTICALS, INC | $22.91 | 1 |
| Celltrion USA Inc. | $15.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.31 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104892791 | CMS |
| ABBVIE INC. | $24.75 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104892793 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $128.17 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146962647 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.46 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118024828 | CMS |
| Celltrion USA Inc. | $15.78 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1075854533 | CMS |
| GENZYME CORPORATION | $25.38 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139970745 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $22.91 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153717708 | CMS |
| Madrigal Pharmaceuticals | $25.51 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144174405 | CMS |
| Madrigal Pharmaceuticals | $17.77 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144174407 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.